Meyka Pro banner
ICICI Bank Limited

Stay Updated with the Latest ICICI Bank Limited IBN News in Real Time

Find IBN news now at Meyka AI. Stay informed with the latest ICICI Bank Limited stocks updates, including price news, market analysis, and expert insights.

IBNNYSE
Financial ServicesBanks - Regional
$29.86
$0.29(0.96%)
U.S. Market opens in 6h 45m
Indian Stock Market Today: SENSEX Jumps 350 Points, NIFTY50 Above 24,150 as IT Stocks Rally
📅 in about 4 hours

Indian Stock Market Today: SENSEX Jumps 350 Points, NIFTY50 Above 24,150 as IT Stocks Rally

Indian stock market indices extended gains through Friday morning, August 28, 2026, led by a sharp IT sector rally. The Sensex climbed roughly 366 points, or 0.47%, to near 77,295. The Nifty50 pushed past 24,168, building on its early gains. Nifty IT rose over 1% as traders awaited Fed Chair Kevin Warsh’s Jackson Hole remarks….

Read more 12
Bank Holiday Today, August 28: Are Banks Closed for Raksha Bandhan? Check State-Wise List
📅 in about 4 hours

Bank Holiday Today, August 28: Are Banks Closed for Raksha Bandhan? Check State-Wise List

Bank holiday today, August 28, 2026, applies to 11 states and union territories for Raksha Bandhan. The RBI holiday calendar confirms closures across Gujarat, Rajasthan, Uttar Pradesh, and several other regions. Banks in Delhi, Maharashtra, West Bengal, Karnataka, and Tamil Nadu remain open as usual. Customers can still access digital services like UPI and net…

Read more 12
NCLT Approves Subhash Chandra Settlement: ₹22,006 Crore Debt Cut to ₹6.5 Crore
📅 in about 3 hours

NCLT Approves Subhash Chandra Settlement: ₹22,006 Crore Debt Cut to ₹6.5 Crore

NCLT approves Subhash Chandra’s settlement plan: ₹22,006 crore debt reduced to ₹6.5 crore with 99.97% haircut. HDFC Bank considers appeal as Congress criticizes ruling.

Read more 12
Mizuho Sues Radiant World in Singapore Court as Police Probe Widens
📅 in about 3 hours

Mizuho Sues Radiant World in Singapore Court as Police Probe Widens

Singapore police raid Radiant World’s office investigating falsified documents. Mizuho Bank files court injunction against the iron ore trader on August 28 as five banks discover fake invoices.

Read more 12
Yash’s Toxic Hits Rs 140 Crore Gross on Day 1, Then Loses Steam on Day 2
📅 4 hours ago

Yash’s Toxic Hits Rs 140 Crore Gross on Day 1, Then Loses Steam on Day 2

Yash’s Toxic opens with Rs 101.10 crore net on Day 1, one of India’s biggest openers, but drops 84% on Day 2 to Rs 16.48 crore as mixed reviews and trolls emerge.

Read more 12
Loblaw Restores Tariff Labels as Trade War Reignites August 27
📅 5 hours ago

Loblaw Restores Tariff Labels as Trade War Reignites August 27

Loblaw reinstates tariff ‘T’ symbols and country-of-origin produce labels on August 26 amid escalating Canada-U.S. trade war and consumer pressure to support domestic suppliers.

Read more 12
Hyperliquid Surges 3.2% to $85.08 as Tokenized Stocks Launch Drives Volume
📅 5 hours ago

Hyperliquid Surges 3.2% to $85.08 as Tokenized Stocks Launch Drives Volume

HYPEUSD rallied 3.2% to $85.08 on August 27 following Hyperliquid’s launch of tokenized stocks and AQAv2 buyback engine on August 26.

Read more 12
Apple Confirms iPhone 18 Pro Event for September 9, Foldable Phone Expected
📅 6 hours ago

Apple Confirms iPhone 18 Pro Event for September 9, Foldable Phone Expected

Apple confirms September 9 event for iPhone 18 Pro and foldable iPhone launch. New CEO John Ternus debuts. Pre-orders likely September 12, retail launch September 18.

Read more 12
AstraZeneca (AZN) and Amgen’s Tezspire Succeeds in Late-Stage Oesophagus Disease Trial
📅 13 hours ago

AstraZeneca (AZN) and Amgen’s Tezspire Succeeds in Late-Stage Oesophagus Disease Trial

AstraZeneca said Thursday its drug Tezspire met all primary and secondary goals in a late-stage trial. The Phase III CROSSING trial tested Tezspire against placebo in eosinophilic oesophagitis (EoE). AstraZeneca developed the drug jointly with Amgen for this chronic inflammatory oesophagus condition. What the CROSSING Trial Showed The Phase III CROSSING trial evaluated two once-every-four-week…

Read more 12

IBN News FAQ